MMED Company Profile and Key Details

MiniMed Group, Inc. Common Stock (NASDAQ:MMED) closed at $16.10 USD, gaining $0.81 (5.30%) from the previous close of $15.29. The stock is currently mid-range between its 52-week high and low $10.65 and $20.48. With a market capitalization of about $4.52 billion, MiniMed Group, Inc. Common Stock is classified as a mid-cap and shows lower-than-market volatility (beta ~-3.63). Key stats such as the average daily volume over the past year has been around 921.35 thousand shares, trading with heavier-than-usual volume. Headquartered in Northridge, CA, MiniMed Group, Inc. Common Stock operates in the Healthcare sector and the Medical - Equipment & Services industry. Led by CEO Que Thanh Dallara, the company employs approximately 8,000 people and listed since March 05, 2026. MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management.

Average 10-day trading volume of 889.12 thousand shares is in line with the 3-month average of 929.29 thousand, indicating normal recent market interest.

MiniMed Group, Inc. Common Stock trades at a P/E ratio of -14.43, slightly below the S&P 500 average, with a price-to-sales ratio of 1.9 and a price-to-book ratio of 1.18 suggesting the stock is closer to book value. The P/FCF stands at -23.83, also below market averages.

MiniMed Group, Inc. Common Stock last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $44.83. This means the shares are trading below this model’s fair value.

Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 5 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $27.00 to $16.00. The high target offers 67.7% upside. The low target suggests -0.62% downside. The mean target is $22.08. This offers 37.14% upside. MiniMed Group, Inc. Common Stock earnings surprise history is a mixed track record. The quarter that ended June 03, 2026, missed forecasts by 356.16%. The prior quarter beat by 17.51%. Over the last six quarters, Apple has recorded several small beats. These include 17.51% in April 17, 2026.

Our AI price prediction model suggests that MiniMed Group, Inc. Common Stock stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.75%, with price expected at $16.22 by July 27, 2026, within a range of $15.43 to $17.05 3-Month Outlook: Projected fall of -97.64%, reaching $0.38 by October 08, 2026, with a range of $0.27 to $0.51. 1-Year Outlook: Projected gain of 1662.73%, with price at $283.80 by July 13, 2027, within a range of $283.63 to $283.93.

Valuation shows MiniMed Group, Inc. Common Stock trading at a premium to the broader market with a P/E of -14.43. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $22.08, suggesting 37.14% upside. Our AI forecast model points to short-term strength (0.75% over two weeks), a medium-term fall (-97.64% over three months), and a longer-term gain (1662.73% over one year), with expected trading ranges indicating moderate volatility.